
Regulatory Hurdles Grow for Generative AI in Diagnostics
The MHRA has signaled a stricter stance on black-box algorithms in clinical settings.
Marcus Vane · 7 min
Section
Imaging, diagnostics, robotics, and medical device markets.

The MHRA has signaled a stricter stance on black-box algorithms in clinical settings.

Cost-benefit analyses show a seven-year break-even point.

Multi-year framework agreements are unraveling.